Drug Pricing Policy Has Been Challenging: Vinita Gupta
  • Gaurav Sarkar
  • Aug 08 2013

The pharma industry is worried about its margins owing to the new drug pricing policy. Vinita Gupta, Group President & CEO at Lupin Pharmaceuticals, says there needs to be a balance between enabling company margins to allow for reinvestment and providing benefits to the patient. “The government is struggling to strike a balance with the policy,” she says.